Table 2: Comparison between chronic hepatitis C before and after treatment. IL6: Interleukin 6; TNFRI: Tumor Necrosis Factor Receptor I; ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; TBil: Total Bilirubin; D.Bill: Direct Bilirubin; INR: International Normalized Ratio of Prothrombin Time of Blood Coagulation; Hb: Hemoglobin; Alb: Albumin; AFP: Alpha Fetoprotein; TSH: Thyroid Stimulating Hormone; BMI: Body Mass Index; WBC: white blood cells. *P< 0.05. |
|||||
Variable |
CHC before treatment N=50 |
CHC after treatment N=50 |
P= value |
||
Mean |
SE |
Mean |
SE |
||
IL6 (Pg/ml) |
265.97 |
14.855 |
343.6 |
10.921 |
0.000* |
TNFRI (Pg/ml) |
76.394 |
12.4305 |
59.346 |
9.812 |
0.000* |
ALT (IU/L) |
59.18 |
2.772 |
36.26 |
1.481 |
0.000* |
AST (IU/L) |
62.62 |
3.424 |
46.66 |
3.379 |
0.003* |
T BIL (g/dl) |
1.06 |
0.0579 |
2.97 |
1.1385 |
0.101 |
D BIL(g/dl) |
0.254 |
0.0236 |
0.292 |
0.0384 |
0.379 |
Alb (g/dl) |
3.834 |
0.0461 |
3.376 |
0.1478 |
0.004* |
INR (%) |
1.238 |
0.0253 |
1.24 |
0.0228 |
0.96/div> |
Glucose (mg/dl) |
99.24 |
2.44 |
96.47 |
4.367 |
0.606 |
Hb (g/dl) |
12.01 |
0.258 |
9.96 |
0.242 |
0.000* |
TSH (ng/dl) |
3.67 |
0.107 |
3.74 |
0.224 |
0.756 |
Serum AFP (ng/ml) |
13.04 |
1.818 |
15.15 |
3.182 |
0.572 |
Creatinine(mg/dl) |
0.972 |
0.022 |
1.088 |
0.0428 |
0.014 |
Platelets |
291.08 |
10.529 |
210.34 |
6.539 |
0.000* |
WBC |
8024 |
197.299 |
5206.36 |
246.48 |
0.000* |
BMI |
26.98 |
1.334 |
24.42 |
1.09 |
0.184 |